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ogy of this study included review of the relevant literature, assessing the possible 
implementation of the decision rules in the Hungarian context and an overview 
of the applications submitted to the Hungarian HTA office which fell into the third 
quadrant. Results: Three main decision rules of the cost-effectiveness can be 
used in the third quadrant. We came to the conclusion that using the same thresh-
old value requires no additional methodological analysis and it is a decision rule 
which is consistent in every case, but using the other two methods can be justified 
as well if the various stakeholders can reach an agreement on the methodological 
and ethical issues. ConClusions: In our conclusion we suggested using the same 
threshold value as in the first quadrant, although sometimes using the other two 
decision rules can also be justified.
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objeCtives: The objective of this research is to characterize the EUnetHTA [European 
Network for Health Technology Assessment] members based on their influence/
position in their respective national reimbursement process of pharmaceuticals/
other technologies and their responsibility to produce HTAs within their national 
setting. Methods: The organizations, in total counting 69, are rated according to 
their position and decision-making influence within the national reimbursement 
process. Categorizations will be: 1. responsible for the reimbursement decision; 2. 
adviser, scientific supplier in the reimbursement process; 3. not actively involved in 
the reimbursement process. In addition, the production of national HTAs – defined 
as an assessment of at least the relative effectiveness and safety of pharmaceuti-
cals/other technologies - will be explored and rated as: 1. production of HTAs; 2. no 
production of HTAs. Primary source for information gathering will be the websites 
of the EUnetHTA member organizations. Two independent researchers will extract 
the data, a member check will be conducted subsequent. Inclusion criteria for the 
information are: English language, not older than 2013, publicly available. If no infor-
mation is available on the respective websites, general overviews about countries 
are used for additional information research and validation. Results: Preliminary 
results: 1. 13 organizations (19%), 2. 21 organizations (30%), 3. 29 organizations (42%). 6 
organizations did not have available information on their homepage. Validation will be 
conducted through general overviews of the countries. Information regarding the HTA 
production of the 69 organizations is expected soon. ConClusions: The preliminary 
results present that around 50% of the EUnetHTA members are actively involved in 
the reimbursement process as responsible body for the decision-making or as adviser. 
Further research is needed to identify the influence of EUnetHTA members and their 
respective role in the national setting on EUnetHTA work.
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objeCtives: Launch of innovative therapies such as biologics adds substantial 
burden on national healthcare insurance systems. Rising costs of such innovative 
therapies led to the implementation of cost-containments measures, including 
denied or restricted reimbursement compared to licensed indications. Biosimilars’ 
introduction might decrease costs and increase access to biologics. The objective of 
this study was to assess the opportunity of indication extension with current and 
future biosimilars taking the example of the United Kingdom (UK). Methods: We 
conducted a review of licensed indications from European Medicines Agency and UK 
Medicine information website of biologics having biosimilars or best-selling biolog-
ics (around 1 USD billion of global sales per year) expected to have biosimilars in the 
five years to come. Scottish Medicine Consortium (SMC) and National Institute for 
Health and Care Excellence (NICE) review was performed for these drugs to iden-
tify potential restrictions in health technology assessment recommendations and 
rationale. Results: We identified 7 biologics having biosimilars and 15 best-selling 
biologics expected to have a biosimilar within the next 5 years. For the 22 selected 
biologics, we identified 110 licensed indications. Main therapeutic areas were immu-
nology/inflammation and oncology. SMC and NICE restricted or did not recommend 
indications for 94% and 80% of assessed biologics, respectively. Among these drugs, 
20% were recommended with a patient access scheme by NICE and 25% by SMC. 
Apart from the absence of dossier submission, the leading reason for restricted 
or denied recommendations was related to cost-effectiveness. ConClusions: By 
reducing drug acquisition cost, biosimilars are expected to improve incremental 
cost-effectiveness ratio of biologics and likely alleviate their restriction. Biosimilars 
represent a high potential societal value by contributing to pharmaceutical budget 
savings and by extending patient access in markets where originator was restricted 
for reimbursement to specific patient subgroups or not reimbursed at all.
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to the assessment of medicines used at the end of life and for patients with rare 
conditions; introducing a new framework for assessing ultra-orphan medicines; 
and involving pharmaceutical company representatives in the discussion of their 
submission. Results: All SMC meetings have been held in public since May 2014 
with full capacity attendance and positive feedback. Private sessions to discuss 
commercial in confidence information have been kept to a minimum. Twenty end 
of life /orphan medicines have been assessed with input from the new Patient 
and Clinician Engagement (PACE) process since August 2014, with fifteen accepted 
for use and five not recommended. These include four medicines assessed using 
the ultra-orphan framework. Company representatives have been in attendance 
at meetings since November 2014 to help address outstanding questions from the 
Committee and clarify issues if required. ConClusions: SMC has worked closely 
with key stakeholders including clinicians, patient groups and the pharmaceuti-
cal industry to introduce these changes. Early experience suggests that these are 
meeting the desired objectives of increasing transparency, giving patient groups 
and clinicians a stronger voice in decision making and are leading to an increased 
acceptance rate for medicines used at the end of life and rare conditions.
PHP275
sHaPing EuroPEan EarlY dialoguEs: tHE sEEd ProJEct
Harousseau J1, Pavlovic M2, Mouas H2, Meyer F3
1French National Authority for Health (HAS), Saint-Denis La Plaine, France, 2Haute Autorité de 
Santé (HAS), Paris, France, 3French National Authority for Health (HAS), Paris, France
The first Early Dialogue (ED) between companies and a single HTA body in Europe 
took place in 2009. In addition to these ‘single-HTA’ advices, parallel regulatory and 
HTA advices have been organized at the EMA, with a limited number of HTA bodies, 
chosen by the company and each HTA body giving its own advice.objeCtives: In 
2012, the first pilots of multiple HTA ED took place in the frame of the European 
Network for HTA (EUnetHTA), coordinated by Haute Autorité de Santé (HAS). The 
objective was to have a collaborative approach to EDs, HTA bodies agreeing to 
exchange their views, identify the key issues of the development proposed by the 
company, discuss their positions and try to reach consensus advice as far as pos-
sible. Considering the success of this activity (10 EUnetHTA EDs done instead of 
3), the European Commission (DG SANTE) has published a call for tender for the 
conduct of 10 additional ‘multiple-HTA’ EDs and the production of a proposal for 
a permanent model for this activity in Europe. Methods: The SEED consortium, 
gathering 14 HTA bodies, coordinated by HAS, has been selected and has been 
operated since May 2014 (first ED) to October 2015 (final report). Results: 11 
EDs have been conducted (8 on drugs including 4 run in parallel with regulatory 
scientific advice at the EMA and 3 on medical devices). In addition to HTA bod-
ies and companies, patients representatives and health professionals have been 
involved in some EDS. A short survey has been conducted after each ED, allowing 
participants to propose improvements to the procedure, and provide input for 
the permanent model. ConClusions: The main outcomes of the 11 SEED EDs 
and the proposal for the permanent model will be presented for information and 
discussion with the audience.
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objeCtives: TEI, the Hungarian HTA office has been filling out an objective quality-
control checklist questionnaire regarding every submission. It critically evaluates 
them since November 2011. The checklist is based on the study of Inotai et al (2012) 
and allows the health-economic analyses in the submissions to be analysed with a 
standardized set of quality criteria. The goal of our poster was to analyze the data 
gathered from the filled checklists between the years 2011 and 2014, according 
to 14 different criteria, both cumulatively and annually, and exploring the pos-
sible correlations. Methods: During our analysis we gathered the answers to 
relevant questions using a VBA macro. We also checked the validity of the filled 
checklists, arranged the gathered data in a database and presented it on various 
graphs. Results: The total number of filled checklists at TEI was 220 between the 
years 2011 and 2014. The database of checklists allows us to analyze the proportion 
of submissions by two or more criteria, in order to find relevant correlations between 
them. Our results include that if the submission lacked a sensitivity analysis it was 
25 times more likely that the budget impact hadn’t been calculated either. The 
results also showed that the general quality of submissions improved according 
to most indicators during the timeframe in question, the only exception is that 
there are fewer submissions which include sensitivity analyses. ConClusions: 
The checklists allow us to conduct cumulative analyses on the submissions received 
by TEI, which helps to improve the quality of HTA analyses.
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objeCtives: Cost-effectiveness of health technologies is shown by their location 
relative to their comparators on the cost-effectiveness plane. The plain is divided 
into four quadrants by the axes. Methods determining the cost-effectiveness of 
therapies in the first quadrant has been thoroughly developed by the HTA meth-
odology. Cost-effectiveness of therapies in the second and fourth quadrant can be 
determined clearly. However in the third quadrant, where interventions are less 
costly but also less effective, there is a lack of a detailed decision rule regarding the 
cost-effectiveness of therapies. The aim of our poster was to investigate the possible 
decision-making rules which can be used in the third quadrant to assess the cost-
effectiveness. Furthermore we investigated the possible role of technologies in this 
quadrant in investment and disinvestment decisions. Methods: The methodol-
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have regarding to the mineral waters/drinking water. Methods: The target group 
of our study was the 18 year old citizens of Pécs (N= 60) and Bátya (N= 60), in 2013. 
The quantitative study with self-edited questionnaires contained the following 
topics: socio-demographic data, water-consumption habits, knowledge about local 
mineral- and drinking water, experiences, mineral water purchasing and consum-
ing habits, knowledge about the beneficial effects of mineral water on health. As 
a statistical method, we conducted an χ 2 test with a 95% percent of probability 
(p< 0,05), with the help of SPSS 20.0 software. Results: The Bátya population 
prefer “traditional” liquids to citizens of Pécs. Since inhabitants of Bátya consume 
significantly more likely soda everyday than citizens of Pécs (p= 0,025) but the same 
cannot be said for the consumption of syrups (p= 0,682). Also has been confirmed, 
that during the purchase of mineral water the observed population does not con-
sider its mineral content, it is the taste and price that influence them, only after 
these they check the mineral content. Men have significantly more knowledge 
about the effects of mineral water on health (p= 0,047). Who have elementary 
qualifications were significantly more to give false answers which component 
should be taken into consideration in case of high blood pressure, whereas those 
who have a high school or higher education qualification were significantly more 
to know the right answer, the sodium. ConClusions: I had observed lack knowl-
edge about the effects of mineral water on health, as well as about the quality of 
local drinking water. Drinking water suppliers and Policy Administration Services 
of Public Health should emphasize that in Hungary, in most cases, the quality of 
drinking water is appropriate.
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objeCtives: Self-rated health (SRH) is a broad but also reliable measure of general 
health status of a population. This study aims to investigate the inter-temporal 
trends in SRH of the general population in Greece since 2002. Methods: The data-
set is based on four cross-sectional surveys carried out in 2002, 2006, 2011 and 2015 
by the National School of Public Health, Athens, Greece. The samples were 926, 
4003, 6569 and 2012 respectively and representative of the general adult popula-
tion after stratification by age, gender and geographic area). Respondents were 
asked to rate their health on a 0-100 scale. Results: Mean SRH score was 77.7, 
76.7, 75.8 and 74.8 in 2002, 2006, 2011 and 2015 respectively, representing a steady 
decline. A decreasing trend was also detected for the adult Greek population who 
rated their health between 81 and 100, from 42.7% in 2006 to 34.6% in 2011, further 
decreasing to 32.9% in 2015. On the contrary, persons reporting SRH between 61 
and 80 increased by approximately 10% during the same period. Little variation 
is observed among the different geographical regions for all four surveys. From 
a socioeconomic perspective, males, younger persons, higher income and higher 
education groups consistently report higher SRH. Additionally, chronic patients 
reported a statistically significant lower SRH compared to their non-chronically ill 
counterparts. ConClusions: Since 2006, there is a 10% shift of the population from 
the top scores of the SRH distribution to middle level SRH. These findings suggest 
adverse developments about SRH; a fact that is also depicted by the decrease of the 
SRH average. Further research is needed in order to investigate whether the adverse 
socioeconomic changes in Greece during the economic crisis have had an impact 
on SRH for the most vulnerable population groups.
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objeCtives: The aim of the study is to test the health status, level of stress, work 
capacity, sleep quality, necessity and options of recovery among police officers in 
order to reveal employers areas of intervention. Methods: We tried to develop 
a sample representing the active police officers (677 persons) of the Tolna County 
Police Headquarters in a qualitative, cross-sectional survey accomplished in 2014. 
The question groups of the self-edited questionnaire involved the health sta-
tus, self-evaluation of work-stress, health behavior, and sociodemographic data. 
Work Ability Index Questionnaire, Perceived Stress Scale, Groningen Sleep Quality 
Scale, Need for Recovery Scale, Recovery Opportunities Scale. χ 2-test, ANOVA, and 
Kruskall-Vallis test, correlate and linear regression were used with 95% probability 
level (p< 0.05). SPSS version 22.0 program was applied for data analysis. Results: 
Median age was 34.5 years, 84.1% males (n= 296, response rate 44%). Sleep quality 
(p= 0.041) of those in service with work schedule different from other than office 
schedule was worse, the level of stress (p= 0.047), recovery necessity (p= 0.002) 
were higher, and work capacity index (p= 0.040) was significantly lower. The level 
of stress (p= 0.010) and the recovery necessity (p= 0.004) in the age group between 
30 - 35 years were lower than those of the other age group. 51.4% of the subjects 
belonged to excellent work capacity category. Work capacity index decreases 
by the increase of age (p< 0.001). Health status rated worse (r= -0.592; p< 0.001) 
and work rated more stressful (r= -0.315;p< 0.001) resulted in lower work capac-
ity index. ConClusions: Protection and development of the work capacity as 
resources among the police officers are a crucial task for the employers. In this 
way, the presonnel can maintain a better health. Due to the deteriorating health 
status, expansion of medical examinations are required by broadening the scope 
of screening tests. Individual consultations and psychological trainings can sup-
port stress management.
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objeCtives: The Patient Registries Initiative has been established with the goal of 
providing effective recommendations on cross-border interoperability of patient 
registries in the EU area. Substantive efforts have been made to gain an in-depth 
understanding of the actual registry details that pertain to the five levels of inter-
operability (Political context, legal, organizational, semantic and technical interop-
erability). This has led to valuable amount of new data on actual patient registries 
profiles, as well as how the real-world implementation and governance of patient 
registries in the EU area takes place in their particular contexts. Methods: An 
extensive questionnaire aimed at gathering insights into patient registry informa-
tion has been used by PARENT JA since 2013 and has gathered information from 
249 patient registries. Registry holders were queried about registry establishment, 
governance, funding, data sources, data quality indicators, standards used and 
other interoperability-related information. Results: The questionnaire results 
have provided valuable information on registry metadata and an overview of the 
patient registry landscape in the EU. The largest proportion of patient registries 
is condition-based (80%), with the rest corresponding to service-based (18%) and 
product-based (2%). Further referential research of 1122 patient registries operat-
ing in the EU has found similar trends. In the area of registry governance, approxi-
mately two thirds (65%) had public authority or public health representatives 
on their governing boards, with an almost negligible proportion having industry 
or even health insurance representatives (< 2%). ConClusions: The differences 
between surveyed registries are tangible proof of the differences in the ever-shift-
ing EU patient registry landscape. The PARENT Framework has been identified as 
a useful tool for providing insights into cross-domain patient registry profiles and 
should assist in the development of recommendations and services for improv-
ing registry interoperability, while also supporting public health and individual 
registry holder’s needs.
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objeCtives: The RegisPt platform was developed with the purpose of listing and 
characterize all available Patient Registries in Portugal. Methods: RegisPt was 
developed in Microsoft Access 2010 and all variable definitions were done accord-
ing to standardized international classifications. A systematic review of avail-
able literature and web resources was performed in order to identify all relevant 
patient registries. Results: The RegisPt platform is divided into five core modules 
containing comprehensive information from each patient registry (General Data, 
Registry Design, Characterization, Effectiveness and Publications). Effectiveness is 
of utmost importance for Health Technology Assessment (HTA) and is divided into 
two submodules: the exposure submodule (Health Care Service, Pharmaceutical 
Drugs and Medical Devices) and the outcomes submodule composed by its three 
components (Clinical, Humanistic and Economic), with fields for surrogate effec-
tiveness markers and hard clinical endpoints, such as overall survival, and fields 
for direct and indirect costs (e.g. absenteeism and early retirement). This data-
base is an interactive tool that allows users to consult all variables for each reg-
istry and to search with advanced options (e.g. by institution and by disease). The 
RegisPt is an ongoing project, however up to now we identified and listed over fifty 
Portuguese registries, according to the registry definition of the International Society 
for Pharmacoeconomics and Outcomes Research. ConClusions: The RegisPt is a 
first step to better understand and use the available resources for health research 
in Portugal (namely comparative effectiveness, cost-of-illnesses and cost-effective-
ness studies). In the future this valuable platform may be used by researchers and 
Authorities for HTA.
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objeCtives: The current study was design to find the prevalence and perception of 
university students in Quetta city regarding cigarettes smoking and allied tobacco 
products. Methods: The study was cross-sectional, Questionnaire based con-
ducted in two Public universities of Quetta city (i.e. University of Balochistan and 
Balochistan University of Information technology, engineering and management 
sciences). The questionnaire was developed and validated in accordance with guide-
lines of global youth tobacco survey. The descriptive statistics was used to present 
the demographic and disease related information. Inferential statistics was used 
to the evaluation relationship among study variables. All analyses were performed 
using SPSS 20.0. Results: A total of 700 questionnaire were distributed and 568 
were returned (response rate of 81.1%). Four hundred seventy three (83.3%) partici-
pants fall in the age group of 20-24, gender distribution was male dominant hav-
ing 426 (75%) male students. One hundred and twenty (21.1%) respondents smoke 
cigarettes and 509 (89.8%) of students use Shisha. ConClusions: The current study 
concluded that the university students smoke cigarettes and shisha. A high rate 
of shisha smoking is higher as compare to cigarette. The efforts should be made 
to educate the students from the hazards of use of tobacco and allied products.
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objeCtives: The aim of our research was to measure the water-consumption 
habits of citizens of Pécs and Bátya, to find, what knowledge and experience they 
